X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Tilidine is a WHO-step-II opioid painkiller and in Germany almost always available in a fixed combination with naloxone, known as Valoron N. About 4 million pain patients in Germany receive opioids (a German figure), many of them tilidine as an entry point before stronger substances. Unlike the prolonged-release tablets, which are not controlled drugs, the fast-acting drops have been subject to Germany's controlled-drugs law since 2013 — misuse had increased above all among adolescents. (Note: tilidine is a continental-European opioid and is not marketed in the UK or US.)
.gif)
Never combine tilidine with alcohol or sedatives - a danger to life through respiratory depression. After longer use, do not stop abruptly. With very slow breathing, unrousability, or blue lips, call the emergency number immediately (999 or 112 in the UK, 112 across the EU). Tilidine is a continental-European opioid and is not marketed in the UK or US. As of May 2026.
Tilidine is a WHO-step-II opioid painkiller, in Germany almost always in a fixed combination with naloxone. Below are the key facts for quick orientation; the individual points are explained in detail in the chapters that follow. (A note on availability: tilidine is used in Germany and some other continental-European countries; it is not marketed in the UK or US, where comparable step-II opioids such as codeine, dihydrocodeine, or tramadol are used instead.)
| Property | Details |
|---|---|
| Active ingredient | Tilidine (a prodrug, active as nortilidine) - mostly with naloxone |
| Brand names | Valoron N, tilidine-naloxone generics - drops and prolonged-release tablets |
| ATC code | N02AX51 - opioids in combination |
| WHO step | II - a moderately strong opioid |
| Mechanism of action | Activation of μ-opioid receptors (nortilidine); the naloxone component blocks the "high" with misuse (IV) |
| Main indications | Moderate to severe pain, when non-opioid painkillers are not enough |
| Usual dose | Prolonged-release tablets 2× a day; drops as needed - set individually by the doctor |
| Onset of effect | Drops 10-30 min; prolonged-release tablets delayed over hours |
| Controlled-drug status (Germany) | Drops subject to Germany's controlled-drugs law since 2013; prolonged-release tablets not |
| Most important risks | Respiratory depression (especially with alcohol/benzodiazepines), dependence, constipation |
| Antidote | Naloxone (also in the preparation; an emergency antidote) |
Tilidine is an opioid painkiller used with moderate to severe pain when weaker painkillers are not enough. It belongs to the weakly to moderately strong opioids (WHO step II) and is, in Germany, almost always offered in a fixed combination with the substance naloxone - known under the brand name Valoron N. This combination has an important safety reason, which we explain in detail. (Tilidine is a continental-European opioid; it is not marketed in the UK or US.)
Tilidine is an effective painkiller that is easy to control with correct use. In recent years, however, it has also gained a sad notoriety through misuse - above all among adolescents and in certain scenes. This has led to stricter rules and makes a factual explanation of effect, risks, and safe handling particularly important.
Like all opioids, tilidine can be addictive and dangerous in overdose - above all in combination with other dampening substances. At the same time, it is a valuable medication for many pain patients. This article explains responsible handling, without playing things down and without dramatizing.
Tilidine itself is at first barely effective - it is a so-called prodrug. Only in the liver is it converted into the actually effective substance nortilidine. Nortilidine binds to the opioid receptors (above all μ-receptors) in the central nervous system and there dampens the perception and transmission of pain - similar to the body's own endorphins, only stronger.
This activation of the opioid receptors brings about the pain-relieving effect, but is also responsible for the typical opioid side effects: tiredness, constipation, nausea, and at a high dose the dangerous respiratory depression. The potential for dependence also rests on the effect at these receptors - via the body's own reward system.
Tilidine is taken up well after oral intake and converted in the liver to nortilidine. The effect of the drops sets in rapidly (within 10-30 minutes), that of the prolonged-release tablets delayed and evenly over hours. The metabolism via the liver also means: with a severe liver function disturbance, the conversion to the effective nortilidine can be impaired, which changes the effect.
A clever and important safety principle that distinguishes tilidine from other opioids. The combination partner naloxone is an opioid antagonist - it blocks the opioid receptors and reverses the opioid effect. Why combine a painkiller with its own antagonist? The answer lies in the different behavior depending on the route of intake.
If tilidine/naloxone is swallowed as intended, the naloxone is almost completely broken down at the first liver passage (a strong first-pass effect) - it has practically no effect. The tilidine, by contrast, is converted to the effective nortilidine and can develop its pain-relieving effect fully. With use as directed, the naloxone therefore does not interfere.
If, on the other hand, the medication is misused by injection (intravenously) to achieve a "high," the naloxone bypasses the liver - and immediately blocks the opioid receptors. The hoped-for state does not occur, and in opioid-dependent people withdrawal can even be triggered. With a massive oral overdose too, naloxone can partly counter-regulate.
This abuse deterrence is the reason for the combination - it is intended to make intravenous misuse unattractive. Misuse cannot be completely prevented by it, however, which explains the additional regulatory measures (see the chapter on drops vs. tablets).
Tilidine is used with moderate to severe pain that cannot be adequately treated with non-opioid painkillers (such as ibuprofen, paracetamol [acetaminophen in the US], metamizole):
Tilidine is on step II of the WHO analgesic ladder of pain therapy - between the non-opioid painkillers (step I) and the strong opioids such as morphine (step III). It is often combined with non-opioid painkillers, in order to act at different points of the development of pain. The indication and dosing are set by the doctor within a well-thought-out pain concept.
A central and safety-relevant difference with tilidine - the two dosage forms behave completely differently and are subject to different rules:
| Aspect | Tilidine drops | Tilidine prolonged-release tablets |
|---|---|---|
| Onset of effect | Fast (10-30 min) | Slow, even over hours |
| Build-up | A fast build-up - a noticeable effect | No fast build-up |
| Misuse potential | Higher | Lower |
| Legal status (Germany) | Subject to the controlled-drugs law since 2013 | A normal prescription (not a controlled drug) |
| Indication | Acute pain peaks, as-needed medication | Long-term therapy of chronic pain |
| Advantages | Fast help with pain peaks | Even pain protection, less risk of misuse |
This distinction explains the different regulation. The situation in Germany: the fast-building drops were made subject to the controlled-drugs law (Betäubungsmittelgesetz, BtMG) in 2013, after their misuse - above all among adolescents - had increased. For the long-term therapy of chronic pain, the prolonged-release tablets are standard, because they work more evenly and have less potential for misuse. (Controlled-drug scheduling differs by country; in the UK and US, opioids are placed in national controlled-substance schedules, and tilidine itself is not marketed there.)
The dosing is always set individually by the doctor - depending on the strength of pain, prior experience with opioids, and general condition:
A central and serious topic with tilidine. Like all opioids, tilidine can cause physical and psychological dependence. The risk depends strongly on the dosage form, dose, duration, and individual factors.
With correct use in pain therapy - above all with prolonged-release tablets and under medical supervision - the risk of dependence is manageable, but present. With longer use, a physical habituation develops, so that withdrawal symptoms can occur when stopping (see the stopping chapter). That is not the same as an addiction disorder, but requires a controlled tapering.
Tilidine - above all the drops - has in recent years gained a sad notoriety through misuse, partly promoted by its portrayal in certain music and social media. The misuse aims at the dampening, euphoric, or disinhibiting effect. The naloxone combination and the controlled-drug status of the drops are intended to counter this.
With such signs, medical help is important - an opioid dependence is treatable, and acting early is decisive.
Tilidine has the typical opioid side effects. Common, above all at the start:
Particularly important - the constipation: unlike most other opioid side effects, the opioid-induced constipation does not disappear through habituation. With longer use, an accompanying treatment is therefore important (a fiber-rich diet, drinking enough, a doctor-prescribed laxative if appropriate).
The most dangerous risk of all opioids - with tilidine too. In overdose, opioids can dampen breathing (respiratory depression) up to respiratory arrest. That is the most common reason for fatal opioid poisonings.
With use as directed in pain therapy, the risk of respiratory depression is low - it becomes critical with overdose and dangerous combinations. It is precisely for this that the maximum dose and the ban on alcohol are so important.
Tilidine has clinically very relevant interactions - above all with other dampening substances:
| Substance/category | Effect | Recommendation |
|---|---|---|
| Alcohol | An enhanced dampening and respiratory depression | Strictly avoid - a danger to life |
| Benzodiazepines (diazepam, lorazepam, Tavor and others), Z-drugs (zolpidem) | A strongly increased risk of respiratory depression | A dangerous combination - only under a strict indication |
| Other opioids | An additive effect, respiratory depression | Never without medical instruction |
| Sedating antidepressants (mirtazapine, tricyclics) | An enhanced dampening | Caution, low doses |
| Antipsychotics | An enhanced sedation | Caution |
| Gabapentin, pregabalin | An increased risk of respiratory depression (BfArM warning) | Only under medical supervision |
| Buprenorphine, naltrexone (opioid antagonists) | Can reverse the tilidine effect or trigger withdrawal | Do not combine |
| Liver-enzyme-modifying medications | Can change the conversion to nortilidine | Consult a doctor |
The combination with benzodiazepines is particularly critical and a common factor in opioid deaths. Before every new medication, consult a doctor/pharmacist. The increased risk of respiratory depression with gabapentinoids (pregabalin, gabapentin) is the subject of a warning from BfArM (Germany) and the FDA (US). More under drug interactions and taking medications correctly.
The danger is real and often underestimated: while tilidine at a therapeutic dose on its own is mostly well tolerated, even a moderate amount of alcohol can dangerously enhance the dampening effect. This applies to all dosage forms. Throughout the entire tilidine therapy, alcohol should be consistently avoided - even small amounts.
After longer use, tilidine must not be stopped abruptly - the body has become used to the opioid, and a sudden stop triggers a withdrawal syndrome:
Possible withdrawal symptoms: restlessness, anxiety, sleep disturbances, sweating, goosebumps, muscle and limb pain, abdominal cramps, diarrhea, nausea, a racing heart, watering eyes and a runny nose, strong craving. These are unpleasant, but largely avoidable with controlled tapering.
The occurrence of withdrawal symptoms with abrupt stopping is an expression of the physical habituation and not a sign of moral failure. With a planned tapering, the stopping is well doable.
| Observation | Frequency | Typical comment |
|---|---|---|
| Constipation as the main problem after weeks | Very common | "After 3 weeks of tilidine for back pain, the constipation was worse than the pain - my GP then prescribed a laxative alongside straight away." |
| A self-directed dose increase with tolerance | Common | "I increased the dose myself because it no longer worked - instead of going to the doctor, which would have been much wiser." |
| Respiratory depression with pregabalin | Rare, but dramatic | "My father took tilidine and Lyrica - one night he was barely breathing, the paramedics gave naloxone." |
| Accidentally a beer in the evening | Common | "I had forgotten that I had taken tilidine in the morning - the beer in the evening knocked me out completely, I could barely stand." |
| Withdrawal after self-stopping | Common | "After 3 months I thought I was cured - the abrupt stopping was hell, now at a pain specialist for a structured tapering." |
| Drops misuse in the family setting | Common | "My drops were suddenly empty - my son (16) had shared them for 'fun' with friends, a bad wake-up call for everyone." |
Tilidine experiences with chronic pain - how long may you take it? That is an individual decision of the pain specialist. With chronic non-cancer pain, the German LONTS guideline recommends a cautious setting of the indication and a regular review of the benefit. Typical treatment durations: acute postoperative pain days to weeks, acute back-pain flares a few weeks, chronic degenerative pain months to years (with regular attempts at a break), cancer pain often lifelong. Risks of a long-term therapy: the development of tolerance (ever higher doses for the same effect), dependence, opioid-induced hyperalgesia (a paradoxical strengthening of pain through the opioids themselves), hormonal disturbances, constipation. In practice: consider a withdrawal attempt every 3-6 months, to test whether the opioid is still needed.
Tilidine experiences with addiction - how do I notice that I am dependent? An honest and important question. Early warning signs: I take the tablets prophylactically before the pain, I think frequently about the next intake, I am afraid of "no longer having it," I go to several doctors for prescriptions. Middle stages: a dose increase beyond the medical prescription, concealing the intake from family/doctors, social activities are planned around the intake. Late stages: a loss of control, use despite negative consequences, physical withdrawal symptoms with longer breaks. Important: physical habituation (withdrawal symptoms when stopping) is not the same as addiction - it occurs with purely medical use too. True addiction additionally has the psychological component (craving, a loss of control). With suspicion: an honest conversation with the doctor, addiction counseling, in severe cases inpatient withdrawal - all possibilities exist without stigma.
Tilidine vs. tramadol - which is better? Both are WHO-step-II opioids with a similar relief of pain, but important differences. Tilidine advantages: the naloxone abuse deterrence, the prolonged-release form for long-term therapy without a controlled-drug prescription, easy to control. Tilidine disadvantages: the drops subject to the controlled-drugs law, a higher misuse potential of the drops, liver-dependent metabolism (caution with liver damage). Tramadol advantages: not subject to the controlled-drugs law, an additional serotonergic/noradrenergic effect (good with nerve pain), often cheaper. Tramadol disadvantages: a risk of serotonin syndrome with an SSRI combination, a higher risk of seizures, a higher side-effect profile (nausea). Rule of thumb: with a nerve-pain component tramadol, with purely nociceptive pain tilidine, with SSRI therapy rather tilidine (no risk of serotonin syndrome). Both with caution with a history of addiction.
Tilidine in the rap scene - what is behind it? A sad cultural reality. Tilidine drops became a symbol of certain German rap subcultures in the 2010s, with a massive playing-down in songs and social media. The effect in misuse doses: euphoria, disinhibition, insensitivity to pain, an overestimation of oneself - from which the "coolness" staging is explained. The reality: a rapid development of tolerance, dependence within weeks, respiratory arrest with combinations, social and health destruction. Several artists have died from tilidine or mixed use. The authorities' reaction: the controlled-drug status of the drops in 2013, school prevention programs, more education. Parents should know: if tilidine is prescribed in the household (e.g. after an operation), store it safely - the availability in the home medicine cabinet is an entry risk.
Getting rid of tilidine constipation - what really helps? Opioid-induced constipation is the most stubborn opioid side effect and does not disappear through habituation. Basic measures (often not enough): 2-3 liters of water a day, a fiber-rich diet (whole grains, fruit, vegetables), regular exercise, prunes, linseed. With longer opioid therapy mostly needed: osmotic laxatives such as macrogol (well tolerated, the agent of choice), stimulants such as bisacodyl (OK short-term), lactulose. With failure: special PAMORA substances such as naloxegol or methylnaltrexone - they specifically block the opioid receptors in the gut without reversing the relief of pain. Important: treat constipation early and prophylactically - do not wait until it is there. At the start of every opioid therapy, start with macrogol straight away.